Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
McKechnie Duncan
EVP, Chief Commercial Officer at Vertex Pharmaceuticals. Filing since 25 Feb 2026.
CIK 0002062139
Company
Date
Role
Action
Shares
Amount
Of holding
VRTX
Vertex Pharmaceuticals
2 Jul 2026
EVP, Chief Commercial Officer
Sold on a plan
1,541
$799.78K
12.3%
VRTX
Vertex Pharmaceuticals
11 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
2,633
$1.31M
17.4%
VRTX
Vertex Pharmaceuticals
4 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
2,437
$1.16M
13.9%
VRTX
Vertex Pharmaceuticals
25 Feb 2026
EVP, Chief Commercial Officer
Sold on a plan
4,910
$2.39M
21.9%
4 decisions on file.
